These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
600 related items for PubMed ID: 23222821
1. Epidemiology of posttransplantation lymphoproliferative disorder in adult renal transplant recipients. Morton M, Coupes B, Roberts SA, Klapper PE, Byers RJ, Vallely PJ, Ryan K, Picton ML. Transplantation; 2013 Feb 15; 95(3):470-8. PubMed ID: 23222821 [Abstract] [Full Text] [Related]
2. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center]. Franco A, Jiménez L, Aranda I, Alvarez L, González M, Rocamora N, Olivares J. Nefrologia; 2002 Feb 15; 22(5):463-9. PubMed ID: 12497748 [Abstract] [Full Text] [Related]
3. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study. Hosseini-Moghaddam SM, Alhomayeed B, Soliman N, Weir MA, House AA. Transpl Infect Dis; 2016 Jun 15; 18(3):423-30. PubMed ID: 27016725 [Abstract] [Full Text] [Related]
4. Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients. Sampaio MS, Cho YW, Shah T, Bunnapradist S, Hutchinson IV. Transplantation; 2012 Jan 15; 93(1):73-81. PubMed ID: 22129761 [Abstract] [Full Text] [Related]
5. Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients. Colombini E, Guzzo I, Morolli F, Longo G, Russo C, Lombardi A, Merli P, Barzon L, Murer L, Piga S, Ciofi Degli Atti ML, Locatelli F, Dello Strologo L. Pediatr Nephrol; 2017 Aug 15; 32(8):1433-1442. PubMed ID: 28280938 [Abstract] [Full Text] [Related]
6. Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients. Sampaio MS, Cho YW, Shah T, Bunnapradist S, Hutchinson IV. Nephrol Dial Transplant; 2012 Jul 15; 27(7):2971-9. PubMed ID: 22273720 [Abstract] [Full Text] [Related]
7. Posttransplant Lymphoproliferative Disorders in Irish Renal Transplant Recipients: Insights From a National Observational Study. OʼRegan JA, Prendeville S, McCaughan JA, Traynor C, OʼBrien FJ, Ward FL, OʼDonovan D, Kennedy C, Berzan E, Kinsella S, Williams Y, OʼKelly P, Deady S, Comber H, Leader M, Conlon PJ. Transplantation; 2017 Mar 15; 101(3):657-663. PubMed ID: 27214265 [Abstract] [Full Text] [Related]
8. Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience. Muchtar E, Kramer MR, Vidal L, Ram R, Gurion R, Rosenblat Y, Bakal I, Shpilberg O. Transplantation; 2013 Oct 15; 96(7):657-63. PubMed ID: 23823652 [Abstract] [Full Text] [Related]
9. Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients. Shahinian VB, Muirhead N, Jevnikar AM, Leckie SH, Khakhar AK, Luke PP, Rizkalla KS, Hollomby DJ, House AA. Transplantation; 2003 Mar 27; 75(6):851-6. PubMed ID: 12660514 [Abstract] [Full Text] [Related]
10. The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients. Wareham NE, Mocroft A, Sengeløv H, Da Cunha-Bang C, Gustafsson F, Heilmann C, Iversen M, Kirkby NS, Rasmussen A, Sørensen SS, Lundgren JD, MATCH in PERSIMUNE study group. J Cancer Res Clin Oncol; 2018 Aug 27; 144(8):1569-1580. PubMed ID: 29804164 [Abstract] [Full Text] [Related]
15. Induction of pre-transplant Epstein-Barr virus (EBV) infection by donor blood transfusion in EBV-seronegative recipients may reduce risk of post-transplant lymphoproliferative disease in adolescent renal transplant patients: report of two cases. Babel N, Gabdrakhmanova L, Hammer M, Rosenberger C, Oppert M, Volk HD, Reinke P. Transpl Infect Dis; 2005 Feb 27; 7(3-4):133-6. PubMed ID: 16390402 [Abstract] [Full Text] [Related]
16. Epstein-Barr virus--associated posttransplantation lymphoproliferative disorder with tacrolimus metabolism deterioration in infants after living-donor liver transplantation. Fukushima D, Sato K, Kawagishi N, Ohuchi N, Satomi S. Transplantation; 2015 Jan 27; 99(1):114-9. PubMed ID: 24846306 [Abstract] [Full Text] [Related]
17. Spectrum of Epstein-Barr virus-associated diseases in recipients of allogeneic hematopoietic stem cell transplantation. Xuan L, Jiang X, Sun J, Zhang Y, Huang F, Fan Z, Guo X, Dai M, Liu C, Yu G, Zhang X, Wu M, Huang X, Liu Q. Transplantation; 2013 Sep 27; 96(6):560-6. PubMed ID: 23842192 [Abstract] [Full Text] [Related]
18. Post-transplant lymphoproliferative disorders and Epstein-Barr virus DNAemia in a cohort of lung transplant recipients. Baldanti F, Rognoni V, Cascina A, Oggionni T, Tinelli C, Meloni F. Virol J; 2011 Sep 05; 8():421. PubMed ID: 21892950 [Abstract] [Full Text] [Related]
19. The Changing Epidemiology of Posttransplant Lymphoproliferative Disorder in Adult Solid Organ Transplant Recipients Over 30 Years: A Single-center Experience. Peters AC, Akinwumi MS, Cervera C, Mabilangan C, Ghosh S, Lai R, Iafolla M, Doucette K, Preiksaitis JK. Transplantation; 2018 Sep 05; 102(9):1553-1562. PubMed ID: 29485513 [Abstract] [Full Text] [Related]
20. Epstein Barr viral load monitoring by quantitative PCR in renal transplant patients. Merlino C, Cavallo R, Bergallo M, Giacchino F, Bollero C, Negro Ponzi A, Cavallo G. New Microbiol; 2003 Apr 05; 26(2):141-9. PubMed ID: 12737195 [Abstract] [Full Text] [Related] Page: [Next] [New Search]